LON:SBTX - Skinbiotherapeutics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 13.50 0.00 (0.00 %)
(As of 12/13/2018 04:05 AM ET)
Previous CloseGBX 13.50
Today's RangeGBX 13.40 - GBX 13.95
52-Week RangeGBX 7.07 - GBX 17.75
Volume24,336 shs
Average Volume261,826 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd. SkinBioTherapeutics plc was founded in 2016 and is based in Macclesfield, the United Kingdom.

Receive SBTX News and Ratings via Email

Sign-up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolLON:SBTX
Previous Symbol
CUSIPN/A
Phone+44-161-4682760

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees6
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable

Skinbiotherapeutics (LON:SBTX) Frequently Asked Questions

What is Skinbiotherapeutics' stock symbol?

Skinbiotherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX."

Has Skinbiotherapeutics been receiving favorable news coverage?

Media stories about SBTX stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Skinbiotherapeutics earned a media sentiment score of 0.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the stock's share price in the near term.

Who are some of Skinbiotherapeutics' key competitors?

Who are Skinbiotherapeutics' key executives?

Skinbiotherapeutics' management team includes the folowing people:
  • Dr. Catherine O'Neill, CEO & Director
  • Mr. Douglas John Quinn, CFO, Company Sec. & Director

How do I buy shares of Skinbiotherapeutics?

Shares of SBTX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Skinbiotherapeutics' stock price today?

One share of SBTX stock can currently be purchased for approximately GBX 13.50.

What is Skinbiotherapeutics' official website?

The official website for Skinbiotherapeutics is http://www.skinbiotherapeutics.com/.

How can I contact Skinbiotherapeutics?

Skinbiotherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The company can be reached via phone at +44-161-4682760.


MarketBeat Community Rating for Skinbiotherapeutics (LON SBTX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Skinbiotherapeutics and other stocks. Vote "Outperform" if you believe SBTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2018 by MarketBeat.com Staff

Featured Article: What are retained earnings?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel